Mattila M J, Saarialho-Kere U, Mattila M
Department of Pharmacology and Toxicology, University of Helsinki, Finland.
J Clin Psychiatry. 1988 Aug;49 Suppl:52-8.
A double-blind, placebo-controlled, crossover study in 12 subjects (greater than or equal to 50 years) compared the effects of single oral doses of sertraline (100 mg) and amitriptyline (50 mg) with placebo as assessed by psychomotor function testing. Unlike sertraline and placebo, amitriptyline increased tracking error severity and impaired digit/symbol substitution. Sertraline slightly improved flicker frequency recognition. Both active drugs caused subjective drowsiness, although amitriptyline's effect was greater and of longer duration. Both drugs impaired subjectively assessed performance. Sertraline caused nausea, and amitriptyline, dry mouth; sertraline tended to increase supine systolic blood pressure. The authors conclude that sertraline has a considerably less detrimental effect on psychomotor performance and may have a slight activating effect not found with amitriptyline.
一项针对12名受试者(年龄大于或等于50岁)的双盲、安慰剂对照、交叉研究,通过心理运动功能测试比较了单次口服舍曲林(100毫克)和阿米替林(50毫克)与安慰剂的效果。与舍曲林和安慰剂不同,阿米替林增加了跟踪误差的严重程度,并损害了数字/符号替换能力。舍曲林略微改善了闪烁频率识别能力。两种活性药物均导致主观嗜睡,尽管阿米替林的效果更强且持续时间更长。两种药物均损害了主观评估的表现。舍曲林引起恶心,阿米替林引起口干;舍曲林倾向于增加仰卧位收缩压。作者得出结论,舍曲林对心理运动表现的不利影响要小得多,并且可能具有阿米替林未发现的轻微激活作用。